Ying Sun

Ying Sun


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Theranostics
Verified
Journal Article
Open access
HHHui Huang
Hui Huang
YDYang Dong
Yang Dong
YZYanhua Zhang
Yanhua Zhang
DRDan Ru
Dan Ru
ZWZhihua Wu
Zhihua Wu
YSYing Sun
Ying Sun
Background: Platinum (II) (Pt(II))-based anticancer drugs dominate the chemotherapy field of ovarian cancer. However, the patient's quality of life has severely limited owing to dose-limiting toxicities and the advanced disease at the time of diagnosis. Multifunctional tumor-targeted nanosized ultrasound contrast agents (glutathione (GSH)-sensitive platinum (IV) (Pt(IV)) prodrug-loaded phase-transitional nanoparticles, Pt(IV) NP-cRGD) were developed for precise theranostics against ovarian cancer.

1 August 2021 in Biomaterials
Verified
Journal Article
Closed access
CCChuanrong Chen
Chuanrong Chen
QGQianqian Guo
Qianqian Guo
HFHao Fu
Hao Fu
JYJian Yu
Jian Yu
LWLiting Wang
Liting Wang
YDYourong Duan
Yourong Duan

Verified
Journal Article
Open access
PDF file
JDJing Du
Jing Du
YSYing Sun
Ying Sun
QSQiu-Sheng Shi
Qiu-Sheng Shi
PLPei-Feng Liu
Pei-Feng Liu
MZMing-Jie Zhu
Ming-Jie Zhu
YDYourong Duan
Yourong Duan
Degradation of mRNA by RNA interference is one of the most powerful and specific mechanisms for gene silencing. However, insufficient cellular uptake and poor stability have limited its usefulness. Here, we report efficient delivery of siRNA via the use of biodegradable nanoparticles (NPs) made from monomethoxypoly(ethylene glycol)-poly(lactic-co-glycolic acid)-poly-l-lysine (mPEG-PLGA-PLL) triblock copolymers. Various physicochemical properties of mPEG-PLGA-PLL NPs, including morphology, size, surface charge, siRNA encapsulation efficiency, and in vitro release profile of siRNA from NPs, were characterized by scanning electron microscope, particle size and zeta potential analyzer, and high performance liquid chromatography. The levels of siRNA uptake and targeted gene inhibition were detected in human lung cancer SPC-A1-GFP cells stably expressing green fluorescent protein. Examination of the cultured SPC-A1-GFP cells with fluorescent microscope and flow cytometry showed NPs loading Cy3-labeled siRNA had much higher intracellular siRNA delivery efficiencies than siRNA alone and Lipofectamine-siRNA complexes. The gene silencing efficiency of mPEG-PLGA-PLL NPs was higher than that of commercially available transfecting agent Lipofectamine while showing no cytotoxicity. Thus, the current study demonstrates that biodegradable NPs of mPEG-PLGA-PLL triblock copolymers can be potentially applied as novel non-viral vectors for improving siRNA delivery and gene silencing.

Verified
Journal Article
Open access
PDF file
YZYunkai Zhu
Yunkai Zhu
YSYing Sun
Ying Sun
YCYaqing Chen
Yaqing Chen
WLWeiyong Liu
Weiyong Liu
JJJun Jiang
Jun Jiang
YDYourong Duan
Yourong Duan
The prostate specific membrane antigen (PSMA) is broadly overexpressed on prostate cancer (PCa) cell surfaces. In this study, we report the synthesis, characterization, in vitro binding assay, and in vivo magnetic resonance imaging (MRI) evaluation of PSMA targeting superparamagnetic iron oxide nanoparticles (SPIONs). PSMA-targeting polypeptide CQKHHNYLC was conjugated to SPIONs to form PSMA-targeting molecular MRI contrast agents. In vitro studies demonstrated specific uptake of polypeptide-SPIONs by PSMA expressing cells. In vivo MRI studies found that MRI signals in PSMA-expressing tumors could be specifically enhanced with polypeptide-SPION, and further Prussian blue staining showed heterogeneous deposition of SPIONs in the tumor tissues. Taken altogether, we have developed PSMA-targeting polypeptide-SPIONs that could specifically enhance MRI signal in tumor-bearing mice, which might provide a new strategy for the molecular imaging of PCa.

1 February 2021 in Biomaterials
Verified
Journal Article
Closed access
YZYanhua Zhang
Yanhua Zhang
YDYang Dong
Yang Dong
HFHao Fu
Hao Fu
HHHui Huang
Hui Huang
ZWZhihua Wu
Zhihua Wu
YSYing Sun
Ying Sun

1 February 2020 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
YSYing Sun
Ying Sun
LQLu Qin
Lu Qin
CLChang Liu
Chang Liu
JSJian Su
Jian Su
XZXin Zhang
Xin Zhang
SMShirui Mao
Shirui Mao